Debasish Bandyopadhyay

18PUBLICATIONS
25CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsTe mātauranga kura tuarua Māori (Māori secondary education)Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Mar 28, 2026
Targeted Therapy in Hepatobiliary Pancreatic Cancer (HPC): Advantages and Advancements of Antibody Drug Conjugates, a Type of Chemo-Biologic Hybrid Drugs.

Tushar Deb Nath, Attrayo Mukherjee, Subhash C Chauhan

|Dec 04, 2025
In Silico and In Vitro Identification of New Eugenol Derivatives as Inhibitors of the Spike SARS-CoV-2 Protein Interaction With the ACE2 Host Receptor.

Timoteo Delgado-Maldonado, Alonzo González-González, Adriana Moreno-Rodríguez

|Sep 26, 2025
Phytochemical Analysis and Appraisal of Antiproliferative Activity of Magnolia alejandrae.

José E Caballero-Chávez, Alma D Paz-González, Diana V Navarrete-Carriola

|Apr 17, 2025
Small-Molecule Mitotic Inhibitors as Anticancer Agents: Discovery, Classification, Mechanisms of Action, and Clinical Trials.

Yazmin Salinas, Subhash C Chauhan, Debasish Bandyopadhyay

|Mar 27, 2025
Small Molecule B-RAF Inhibitors as Anti-Cancer Therapeutics: Advances in Discovery, Development, and Mechanistic Insights.

Yamile Abuchard Anaya, Ricardo Pequeno Bracho, Subhash C Chauhan

|Oct 26, 2024
Targeted Therapy in Breast Cancer: Advantages and Advancements of Antibody-Drug Conjugates, a Type of Chemo-Biologic Hybrid Drugs.

Attrayo Mukherjee, Debasish Bandyopadhyay

Pageof 3

Frequent Collaborators

9 joint publications

Gildardo Rivera

2 joint publications

Isidro Palos

2 joint publications

Diana V Navarrete-Carriola

1 joint publications

Fernando P Cossío